Insulet Stock Hits 52-Week Low - Here's Why

Benzinga_recent_news03-13

Insulet Corp. (NASDAQ:PODD) shares are down during Friday’s premarket session following the company’s announcement of a voluntary Medical Device Correction for certain lots of Omnipod 5 Pods. Insulet ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2619118460?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Insulet-Omnipod5-Diabetes.png?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-03-13 21:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619118460","market":"hk","top_or_hot":-1,"title":"Insulet Stock Hits 52-Week Low - Here's Why","media":"Benzinga_recent_news","content":"<div>\n<p>Insulet Corp. (NASDAQ:PODD) shares are down during Friday’s premarket session following the company’s announcement of a voluntary Medical Device Correction for certain lots of Omnipod 5 Pods.\nInsulet ...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/03/51240169/insulet-stock-hits-52-week-low-heres-why\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insulet Stock Hits 52-Week Low - Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsulet Stock Hits 52-Week Low - Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-13 21:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/26/03/51240169/insulet-stock-hits-52-week-low-heres-why><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Insulet Corp. (NASDAQ:PODD) shares are down during Friday’s premarket session following the company’s announcement of a voluntary Medical Device Correction for certain lots of Omnipod 5 Pods.\nInsulet ...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/03/51240169/insulet-stock-hits-52-week-low-heres-why\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PODD","symbol_name":"银休特","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/26/03/51240169/insulet-stock-hits-52-week-low-heres-why","article_id":"2619118460","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Insulet-Omnipod5-Diabetes.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51240169/insulet-stock-hits-52-week-low-heres-why","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619118460","pubTimestamp":1773409500,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Insulet shares fall after the company warns certain Omnipod 5 Pods may under-deliver insulin, linked to reports of serious health events.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PODD":"银休特","BK4588":"碎股","BK4585":"ETF&股票定投概念","SMA":"Smartstop Self Storage REIT Inc","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4082":"医疗保健设备","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK4217":"自存仓储房地产信托","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","BK4551":"寇图资本持仓","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","BK4566":"资本集团","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC"},"translate_title":"Insulet股价触及52周低点——原因如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PODD":1.5,"SMA":1},"content_text":"Insulet Corp. (NASDAQ:PODD) shares are down during Friday’s premarket session following the company’s announcement of a voluntary Medical Device Correction for certain lots of Omnipod 5 Pods.\nInsulet identified a manufacturing issue affecting specific lots of Omnipod 5 Pods, which may have a small tear in the internal tubing that delivers insulin.\nThis could lead to under-delivery of insulin, potentially resulting in high blood glucose levels and serious medical conditions, including diabetic ketoacidosis (DKA); the company has received 18 reports of serious adverse events related to this issue.\nDiabetic ketoacidosis is a life-threatening, critical metabolic emergency, primarily in type 1 diabetes, where insufficient insulin causes the body to burn fat for fuel, producing high levels of blood acids (ketones).\nThe affected Pods represent approximately 1.5% of annual production globally, and Insulet has assured that all other Omnipod products remain safe for use.\nInsulet on Thursday noted that the issue does not affect continuous glucose monitoring (CGM) systems or CGM readings.\nThe stock is currently trading 8.63% below its 20-day simple moving average (SMA) and 14.45% below its 100-day SMA, indicating a bearish trend in the short to medium term. Shares have decreased 3.51% over the past 12 months and are currently positioned closer to their 52-week lows than highs.\nThe RSI is at 37.55, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD is at -6.1188, above its signal line at -6.4232, indicating a bullish crossover that may suggest potential upward momentum.\nThe combination of neutral RSI and bullish MACD suggests mixed momentum, indicating that while there may be some buying interest, the stock is still facing significant selling pressure.\nAnalyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $356.64. Recent analyst moves include:\nBelow is the Benzinga Edge scorecard for Insulet, highlighting its strengths and weaknesses compared to the broader market:\nThe Verdict: Insulet’s Benzinga Edge signal reveals a mixed outlook. While the Growth Rank indicates strong potential, the low Value and Momentum scores suggest that the stock may be overvalued and struggling to gain traction in the current market environment.\nPODD Price Action: Insulet shares were down 4.85% at $224.63 at the time of publication on Friday. The stock is trading at a new 52-week low, according to Benzinga Pro data.\nImage via Insulet\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619118460","isCrawlerRequest":true}